Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) – the leading trade association representing manufacturers of medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound therapeutic devices – today expressed support for the expanded recommendations contained in the latest United States Preventive Services Task Force (USPSTF) draft recommendation statement on breast cancer screening, but also encouraged additional reliance on new clinical guidelines.
USPSTF’s draft recommendation outlines that all women ages 40 to 74 years should be screened for breast...